We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Hogan Lovells Successfully Represents LabCorp in Victory Against Federal Trade Commission

28 February 2011

WASHINGTON, D.C., 28 February 2011 – Hogan Lovells US LLP announced today that the U.S. District Court for the Central District of California recently denied a Federal Trade Commission (FTC) bid to temporarily block Hogan Lovells client, Laboratory Corporation of America (LabCorp), in a $57.5 million deal for rival Westcliff Medical Laboratories Inc.

In early December 2010, the FTC sued to block the acquisition, alleging that LabCorp's acquisition of a medical lab in California violated antitrust laws. The Honorable Andrew J. Guilford denied the FTC's request for a preliminary injunction and also dissolved the temporary restraining order that had been in place since mid-December. He ruled that the FTC had not shown it was likely to succeed on the merits of its case during its administrative proceedings evaluating the merger. The FTC's hearing against the merger is scheduled to begin 2 May 2011.

The Hogan Lovells team representing LapCorp is led by partner and former FTC Chief Trial Council Robby Robertson and partner Corey Roush in the Washington, D.C. office, with assistance from associates Ben Holt, Leigh Oliver, Justin Bernick, Meghan Edwards-Ford, and Will Rawson.

Loading data